Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients

MLA

Kazunori Kihara, et al. “Selective Tetramodal Bladder-Preservation Therapy, Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.” BJU International, vol. 124, Apr. 2019, pp. 242–50. EBSCOhost, https://doi.org/10.1111/bju.14736.

APA

Kazunori Kihara, Kazutaka Saito, Minato Yokoyama, Toshiki Kijima, Junichiro Ishioka, Yasuhisa Fujii, Fumitaka Koga, Soichiro Yoshida, Yoh Matsuoka, Hitoshi Masuda, & Hajime Tanaka. (2019). Selective tetramodal bladder-preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle-invasive bladder cancer: oncological and functional outcomes of 107 patients. BJU International, 124, 242–250. https://doi.org/10.1111/bju.14736

Chicago

Kazunori Kihara, Kazutaka Saito, Minato Yokoyama, Toshiki Kijima, Junichiro Ishioka, Yasuhisa Fujii, Fumitaka Koga, et al. 2019. “Selective Tetramodal Bladder-Preservation Therapy, Incorporating Induction Chemoradiotherapy and Consolidative Partial Cystectomy with Pelvic Lymph Node Dissection for Muscle-Invasive Bladder Cancer: Oncological and Functional Outcomes of 107 Patients.” BJU International 124 (April): 242–50. doi:10.1111/bju.14736.